Impact Of Choice Of Therapy On Survival Outcome Of Patients With Prostate Cancer (A Case Study Of Selected Cancer Patients In University Of Uyo Teaching Hospital)

Impact Of Choice Of Therapy On Survival Outcome Of Patients With Prostate Cancer (A Case Study Of Selected Cancer Patients In University Of Uyo Teaching Hospital)
Abstract
This study examines the impact of choice of therapy on survival outcome of patients with prostate cancer. Faced with the problem of uncertainty regarding the optimal choice of therapy and its impact on the survival outcomes of patients with prostate cancer, as The decision-making process for prostate cancer treatment is multifaceted, considering variables such as cancer stage, aggressiveness, patient preferences, and potential treatment side effects, the study was guided by the following objectives;
- To assess the different treatment options available for patients with prostate cancer in the University of Uyo Teaching Hospital.
- To determine the factors influencing the choice of therapy for prostate cancer patients.
- To examine the survival outcomes of patients based on their choice of therapy.
- To identify any significant associations between specific therapies and survival outcomes.
- To provide recommendations for optimizing therapy choices and improving survival outcomes in patients with prostate cancer.
The study employed descriptive and explanatory design, questionnaires in addition to library research were applied in order to collect data. Primary and secondary data sources were used and data was analyzed using statistical package which was presented in frequency tables and percentage. The respondents under the study were 30 Patients of University Of Uyo Teaching Hospital. The study findings revealed that there is a significant impact which [choice of therapy] has on [survival outcome of patients with prostate cancer]. Linear regression significant at 0.05 level (2-tailed), 0.00 indicates the significance of interaction between two variables an indication that the significant is under the range of 0.0 and 0.05.
Using the above findings, it implied that there is a strong relationship between [choice of therapy] and [survival outcome of patients with prostate cancer]. Key recommendations from the study are;
- Patients should with prostate cancer take the time to educate themselves about prostate cancer, its stages, treatment options, potential side effects, and the latest research developments, seek guidance from a multidisciplinary team of healthcare professionals, including urologists, radiation oncologists, medical oncologists, and other specialists. Engaging with a diverse team will provide a comprehensive understanding of your condition and ensure that your treatment plan is well-informed and personalized.
- They should collaborate closely with your healthcare team in the decision-making process. Share your preferences, goals, and concerns with your doctors, and discuss the potential benefits and risks of various treatment options. Engaging in shared decision-making empowers one to play an active role in the treatment journey and ensures that the treatment aligns with one’s values and priorities
- If eligible, they should also explore the option of participating in clinical trials. Clinical trials can offer access to novel therapies and cutting-edge treatments that may not be available through standard care. Participation in clinical trials not only potentially benefits the Patients but also contributes to advancing medical knowledge and improving future treatments for prostate cancer patients.
Chapter One
Introduction
1.1 Background of the Study
Prostate cancer predominantly targets the male population and ranks as the second most prevalent cancer globally among men, following lung cancer. In 2018, there were 1,276,106 newly reported cases of prostate cancer, leading to 358,989 deaths, which constituted 3.8% of all male cancer-related fatalities (Bray et al., 2018). This form of cancer primarily affects men aged 45 to 60 and stands as a prominent cause of cancer-related mortality in Western nations (Chen et al., 2013).
The diagnosis of prostate cancer commonly involves several procedures, including prostate biopsy, prostate-specific antigen (PSA) testing, digital rectal examination, magnetic resonance imaging (MRI), or health screenings. Various risk factors are associated with prostate cancer, such as family history, ethnicity, age, obesity, and environmental factors.
Prostate cancer displays heterogeneity in both its epidemiology and genetics. The interaction between genetics, environmental influences, and social factors contributes to race-specific variations in survival rates and explains the differences observed in the epidemiology of prostate cancer across different countries (Hjelmborg et al., 2014). There is compelling evidence supporting the influence of genetics in the development of prostate cancer, and extensive research has been dedicated to investigating hereditary factors and genetic predisposition to the disease. Among the genetic risk factors, family inheritance stands out as one of the most significant contributors to prostate cancer.
Studies involving twins and epidemiological investigations have provided substantial confirmation of the involvement of hereditary factors in the development of prostate cancer (Termini et al., 2020). Researchers have delved into the potential impact of genetic variations in androgen biosynthesis and metabolism, as well as the role of androgens themselves. Through genomics research, specific molecular processes, such as chromosomal rearrangements, have been identified as contributing factors to the development of particular types of prostate cancer (Hjelmborg et al., 2014).
Gene mutations play a significant role in the development of cancer, including prostate cancer. Certain genes involved in the androgen pathway and testosterone metabolism have been identified as candidate genes for prostate cancer predisposition. The androgen receptor signaling pathway and testosterone are crucial for the growth of prostate epithelium and prostate cancer cells (Bluemn and Nelson, 2012). Identifying cancer biomarkers and targeting specific genetic mutations can enable targeted treatments for prostate cancer. Examples of biomarkers that can be used for targeted treatment include DNA tumor biomarkers, DNA biomarkers, and general biomarkers (Ziaran et al., 2015).
Prostate cancer can be categorized as either responsive to androgen hormones (androgen-sensitive) or unresponsive (androgen-insensitive), which influences the treatment options available for the disease based on its sensitivity to testosterone stimulation (Takayama, 2019). Treatment choices for prostate cancer encompass a range of approaches, including active surveillance, chemotherapy, radiation therapy, hormonal therapy, surgery, and cryotherapy. The selection of a specific treatment modality depends on several factors, such as the characteristics of the tumor, PSA (prostate-specific antigen) level, cancer grade and stage, and the likelihood of recurrence.
For instance, in cases of low-risk prostate cancer, a combination of radical prostatectomy, a surgical procedure involving the removal of the prostate and surrounding tissues, and radiation therapy may be employed (Bach et al., 2014). Androgen-deprivation therapy, also referred to as hormonal therapy, is recommended for the treatment of prostate cancers that have extended beyond the prostate or have experienced recurrence (Chen et al., 2013).
Each treatment option is associated with significant side effects, including toxicity, reduced white and red blood cell counts, fatigue, hair loss, peripheral neuropathy, erectile incontinence and dysfunction, metastasis, and the development of resistance to initial treatment. Furthermore, available treatment options are costly and can have severe adverse effects (Termini et al., 2020).
Understanding the impact of therapy choices on survival outcomes is essential for healthcare professionals and policymakers in improving patient care and treatment strategies. This study focuses on exploring the impact of the choice of therapy on the survival outcome of patients with prostate cancer in selected cancer patients at the University of Uyo Teaching Hospital.
1.2 Statement of the Problem
Prostate cancer is a significant contributor to cancer-related mortality in men worldwide. Despite advancements in treatment options, there is still uncertainty regarding the optimal choice of therapy and its impact on the survival outcomes of patients with prostate cancer. The decision-making process for prostate cancer treatment is multifaceted, considering variables such as cancer stage, aggressiveness, patient preferences, and potential treatment side effects.
Therefore, it is imperative to conduct research that specifically examines the influence of different therapy choices on the survival outcomes of patients. This research would provide valuable insights to healthcare providers and patients, assisting them in making well-informed decisions regarding the selection of appropriate treatment options.
1.3 Aim of the Study
The aim of this study is to investigate the impact of the choice of therapy on the survival outcome of patients with prostate cancer in the University of Uyo Teaching Hospital.
1.4 Objectives of the Study
The specific objectives of this study are as follows:
- To assess the different treatment options available for patients with prostate cancer in the University of Uyo Teaching Hospital.
- To determine the factors influencing the choice of therapy for prostate cancer patients.
- To examine the survival outcomes of patients based on their choice of therapy.
- To identify any significant associations between specific therapies and survival outcomes.
- To provide recommendations for optimizing therapy choices and improving survival outcomes in patients with prostate cancer.
1.5 Research Questions
To achieve the objectives of this study, the following research questions will be addressed:
- What are the treatment options available for patients with prostate cancer in the University of Uyo Teaching Hospital?
- What factors influence the choice of therapy for prostate cancer patients in the hospital?
- How do different therapies impact the survival outcomes of patients with prostate cancer?
- Are there any significant associations between specific therapies and survival outcomes in patients with prostate cancer?
1.6 Research Hypothesis
- H0: The choice of therapy does not significantly impact the survival outcome of patients with prostate cancer in the University of Uyo Teaching Hospital
- H1: The choice of therapy significantly impacts the survival outcome of patients with prostate cancer in the University of Uyo Teaching Hospital
1.7 Justification of the Study
This study is significant because it addresses an important gap in the understanding of how the choice of therapy affects the survival outcome of patients with prostate cancer. The findings can provide valuable insights for healthcare professionals, patients, and policymakers in making informed treatment decisions and improving patient outcomes. Additionally, the study contributes to the existing literature on prostate cancer treatment and adds to the body of knowledge in this field.
1.8 Scope of the Study
This study focuses specifically on the impact of the choice of therapy on the survival outcome of patients with prostate cancer in the University of Uyo Teaching Hospital. The research will involve collecting primary data through patient interviews, medical records review, and survival outcome assessments.
Chapter Five
Summary of Findings, Conclusion and Recommendations
5.1 Summary of Findings
The first objective of the study was to assess the different treatment options available for patients with prostate cancer in the University of Uyo Teaching Hospital. Findings from the study revealed that Active Surveillance, Surgery (Radical Prostatectomy), Chemotherapy, Hormone Therapy (Androgen Deprivation Therapy – ADT), and Radiation Therapy are the different treatment options available for patients with prostate cancer in the University of Uyo Teaching Hospital.
The second objective of the study was to determine the factors influencing the choice of therapy for prostate cancer patients. Findings from the study revealed that Stage and Grade of Prostate Cancer, Patient’s Health and Age, Clinical Trials and Research, Side Effects and Risks and Treatment Goals are the factors influencing the choice of therapy for prostate cancer patients.
The third objective of the study was to examine the survival outcomes of patients based on their choice of therapy. Findings from the study revealed that Surgery: generally high, often exceeding 90%, Radiation Therapy: 5-year survival rates often exceeding 90%, Hormone Therapy: varying survival outcomes depending on the extent of cancer at the start of treatment and how the cancer responds to hormonal manipulation, Chemotherapy: varying with some patients experiencing significant improvement, while others may have more limited responses, and Immunotherapy and Targeted Therapies: extending survival and delaying disease progression in certain cases are the survival outcomes of patients based on their choice of therapy.
The fourth objective of the study was to identify any significant associations between specific therapies and survival outcomes. Findings from the study revealed that Early Detection and Curative Intent Treatments, Resistance Management, Immunotherapy, Androgen Deprivation Therapy (ADT) and Castration-Resistant Prostate Cancer (CRPC) are significant associations between specific therapies and survival outcomes.
The five objective of the study was to provide recommendations for optimizing therapy choices and improving survival outcomes in patients with prostate cancer. Findings from the study revealed that Early Detection and Screening, Multidisciplinary Care, Risk Stratification and Individualized Treatment, Clinical Trials and Research, and Monitoring and Follow-Up are recommendations for optimizing therapy choices and improving survival outcomes in patients with prostate cancer.
5.2 Conclusion
The paper examines the impact of choice of therapy on survival outcome of patients with prostate cancer. From the responses analysed from the respondents in University Of Uyo Teaching Hospital, and previous empirical studies on the subject matter, the researcher was able to clearly point out that there is a statistical significant relationship between choice of therapy and Survival outcome of patients with prostate cancer.
5.3 Recommendations
Based on the objectives and findings of the research paper, the following are recommendation from the study:
- Patients should with prostate cancer take the time to educate themselves about prostate cancer, its stages, treatment options, potential side effects, and the latest research developments, seek guidance from a multidisciplinary team of healthcare professionals, including urologists, radiation oncologists, medical oncologists, and other specialists. Engaging with a diverse team will provide a comprehensive understanding of your condition and ensure that your treatment plan is well-informed and personalized.
- They should collaborate closely with your healthcare team in the decision-making process. Share your preferences, goals, and concerns with your doctors, and discuss the potential benefits and risks of various treatment options. Engaging in shared decision-making empowers one to play an active role in the treatment journey and ensures that the treatment aligns with one’s values and priorities
- If eligible, they should also explore the option of participating in clinical trials. Clinical trials can offer access to novel therapies and cutting-edge treatments that may not be available through standard care. Participation in clinical trials not only potentially benefits the Patients but also contributes to advancing medical knowledge and improving future treatments for prostate cancer patients.


The Complete Material Will Be Sent to You in Just 2 Steps
Quick & Simple…
![]()
Make Payment (Through Transfer) of ₦5,000 to the Account Below
![]() | Acc No: 0811003731 |
| Samphina Academy | |
| Current Account |
Or CLICK HERE To Pay With Debit Card
| FOR STUDENTS OUTSIDE NIGERIA | |
| CLICK HERE To Pay With Card ($15) | |
| FOR GHANA STUDENTS (GHS 100) | |
![]() | MTN MoMo |
| 0553978005 | |
| Douglas Osabutey | |
![]()
Send the Following Details on WhatsApp ( 07062590260 ) After Payment
- Payment Details
- TOPIC: Impact Of Choice Of Therapy On Survival Outcome Of Patients With Prostate Cancer (A Case Study Of Selected Cancer Patients In University Of Uyo Teaching Hospital)
The Complete Material Will Be Sent To You On WhatsApp After Receiving Your Details
T & C Apply
Students Review
List of Related Works
The Influence Of Prostate Cancer Awareness Campaigns On The Knowledge, Attitude And Practices Of Men
Reality Therapy As A Technique Of Stress Management Among Nigerian Married Women
The Impact Of Music As A Therapy For Depression
Predictors And Risk Factors Of Mental Health Disorders Among Postpartum Women
The Effectiveness Of Behavioral Therapy In Reducing Anxiety
Anxiolytic Potential Of Quassia Undulata Ethyl Acetate Fraction In Open Field Test Model
Breast Cancer Awareness And Practice Of Breast Self-Examination Among Women In Amai Community
Acceptance Of Cervical Cancer Screening And Prevention Among The Rural Women
Knowledge, Attitude And Practice Concerning Cervical Cancer Screening Among Market Women
Design And Implementation Of An Expert System In Diagnosis And Treatment Of Breast Cancer
Hospital Waste Management Practices In Nigeria (A Case Study Of Uyo Teaching Hospital)
Knowledge And Practice Of Infection Control Among Patients In Madonna University Teaching Hospital
Creativity As Cognitive Mapping: It’s Relationship With Hospital Care
The Role Of Confidentiality As An Essential Aspect In Patients Information In The Hospital
The Efficiency Of Exposure Index As It Relates To Patient Dose At Federal Medical Center Asaba
Automated Hospital Record System For Outpatients
Prevalence Of Peptic Ulcer Disease Among Patients In Primary Health Care Settings
Health-Related Quality Of Life Of Diabetes Mellitus Patients And Non-Diabetics
Knowledge Of Hypertension Among Elderly Patients In Madonna University Teaching Hospital
Seroprevalence Of HBC IGM Among HIV Patients In Calabar


